BioSpace News Archive

AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer

Amplia Therapeutics Limited is pleased to announce new data showing the efficacy of its investigational FAK inhibitor, AMP945, in a preclinical model of pancreatic cancer, when used in combination with FOLFIRINOX treatment.

May 29, 2023
·
4 min read
Drug Development

Hummingbird Bioscience Announces HMBD-002 Trials in Progress Poster at ASCO Annual Meeting 2023

Hummingbird Bioscience announced a Trials in Progress poster presentation for HMBD-002, a unique anti-VISTA antibody, at the American Society of Clinical Oncology Annual Meeting being held 2-6 June, 2023 in Chicago.

May 29, 2023
·
4 min read
Roche Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for VABYSMO® (faricimab injection) for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)

Hoffmann-La Roche Limited announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for VABYSMO®, indicated for the treatment of neovascular age-related macular degeneration and diabetic macular edema,1 two of the leading causes of vision loss among Canadians.

May 29, 2023
·
5 min read
Genetown

iNtRON identifies Prophage and Jamphage in the Pancreatic cancer related Microbiome

iNtRON Biotechnology has announced the identification of Prophage and ORF-Jamphage from the microbiome frequently observed in long-term Pancreatic cancer survivors.

May 29, 2023
·
5 min read
Rakovina Therapeutics Inc. Announces Closing of $1.5 Million Convertible Debenture Financing

Rakovina Therapeutics Inc. is pleased to announce that it has closed its previously announced non-brokered private placement of unsecured convertible debenture units of the Company for aggregate gross proceeds to the Company of approximately $1.5 million.

May 29, 2023
·
5 min read
Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models

RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.

May 29, 2023
·
2 min read
Titan Medical Announces Corporate Update and Provides Bi-Weekly MCTO Status Update

Titan Medical Inc. announced a corporate update and is also providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders.

May 29, 2023
·
9 min read
Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study

Immutep Limited announces it has entered into an agreement with Charles River under which Charles River will conduct a GLP toxicology study for IMP761, Immutep’s proprietary preclinical candidate for autoimmune diseases.

May 29, 2023
·
3 min read
Genetown

Novotech Sponsors BIO 2023 APAC Summit and the Endpoints Panel on Forging Biotech Ties with China

Novotech, the leading Asia Pacific centred biotech CRO is sponsoring the BIO 2023 APAC Summit, and the Endpoints session on Forging New Biotech Ties with China.

May 29, 2023
·
3 min read
AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023

AbCellera announced that executives from the Company will present at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, California on Tuesday, June 13, 2023, at 1:20 p.m. Pacific Time.

May 29, 2023
·
1 min read